Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients

Completed

Conditions studied: Overdose

In brief

The purpose of this project is to evaluate the case characteristics of patients who receive intravenous lipid emulsion therapy. Previous literature to date has focused on animal studies or has been primarily limited to case reports or small case series. This prospectively collected data set will permit a much more detailed description of the use of lipid, its potential benefits, and potential harms.

Key facts

Study ID

NCT03107689

Run by

University of Southern California

People needed

134

Starts

2012-05-01

Expected to finish

2018-12-01

Last updated by the study team

2024-03-01

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• receiving intravenous lipid emulsion for treatment of a drug toxicity
• Evaluation of a medical toxicologist as part of the ToxIC registry consortium

You may not qualify if…

• not evaluated by a medical toxicologist participating in ToxIC

Where it is running

• ACMT; ToxIC participating sites — Phoenix, Arizona, United States
• University of Southern California — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.